Does AFLIBERCEPT Cause Polypoidal choroidal vasculopathy? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Polypoidal choroidal vasculopathy have been filed in association with AFLIBERCEPT (EYLEA). This represents 0.2% of all adverse event reports for AFLIBERCEPT.
44
Reports of Polypoidal choroidal vasculopathy with AFLIBERCEPT
0.2%
of all AFLIBERCEPT reports
0
Deaths
2
Hospitalizations
How Dangerous Is Polypoidal choroidal vasculopathy From AFLIBERCEPT?
Of the 44 reports, 2 (4.5%) required hospitalization.
Is Polypoidal choroidal vasculopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AFLIBERCEPT. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does AFLIBERCEPT Cause?
Death (7,669)
Visual impairment (1,836)
Blindness (1,337)
Endophthalmitis (1,289)
Off label use (1,156)
Eye pain (1,057)
Product dose omission issue (1,051)
Blindness unilateral (1,012)
Vision blurred (1,012)
Visual acuity reduced (993)
What Other Drugs Cause Polypoidal choroidal vasculopathy?
Which AFLIBERCEPT Alternatives Have Lower Polypoidal choroidal vasculopathy Risk?
AFLIBERCEPT vs AGALSIDASE ALFA
AFLIBERCEPT vs AGALSIDASE BETA
AFLIBERCEPT vs AGOMELATINE
AFLIBERCEPT vs ALAWAY
AFLIBERCEPT vs ALBENDAZOLE